mirage

Placebo‐controlled, randomized trial of the addition of once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD‐9)

ABACUS/Manakin Repository

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)